Bart M. Van Vlijmen

Leiden, ZH, Netherlands

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 52 publications

Corrigendum to "The effects of an aggressive breast tumor on thrombosis after antithrombin downregulation in a hypercoagulable mouse model" [Thromb. Res. 244 (2024) 109200].

Corrigendum to "The effects of an aggressive breast tumor on thrombosis after antithrombin downregulation in a hypercoagulable mouse model" [Thromb. Res. 244 (2024) 109200].

Journal: Thrombosis research

Published: May 01, 2026

Evaluation of a serum protein signature as monitoring biomarker for Duchenne muscular dystrophy in a long-term clinical trial with corticosteroids.

Evaluation of a serum protein signature as monitoring biomarker for Duchenne muscular dystrophy in a long-term clinical trial with corticosteroids.

Journal: Skeletal muscle

Published: February 11, 2026

Plasma protein profile in patients with antiphospholipid syndrome and controls without APS.

Plasma protein profile in patients with antiphospholipid syndrome and controls without APS.

Journal: Journal of thrombosis and haemostasis : JTH

Published: January 30, 2026

Distinct plasma protein profiles after long-term remission of Cushing's disease.

Distinct plasma protein profiles after long-term remission of Cushing's disease.

Journal: The Journal of clinical endocrinology and metabolism

Published: November 26, 2025

Advancing precision diagnostics in coagulation: introduction and analytical validation of a multiplex mass spectrometry-based test for five coagulation factors.

Advancing precision diagnostics in coagulation: introduction and analytical validation of a multiplex mass spectrometry-based test for five coagulation factors.

Journal: Journal of thrombosis and haemostasis : JTH

Published: September 10, 2025

Advancing precision diagnostics in coagulation: introduction and analytical validation of a multiplex mass spectrometry-based test for 5 coagulation factors.

Advancing precision diagnostics in coagulation: introduction and analytical validation of a multiplex mass spectrometry-based test for 5 coagulation factors.

Journal: Journal of thrombosis and haemostasis : JTH

Published: September 10, 2025

Von Willebrand Factor as a Therapeutic Target in Thrombotic Disorders.

Von Willebrand Factor as a Therapeutic Target in Thrombotic Disorders.

Journal: Thrombosis and haemostasis

Published: August 11, 2025

Corrigendum to "Quantitative protein mass spectrometry for multiplex measurement of coagulation and fibrinolytic proteins towards clinical application: What, why and how?", [Thromb. Res. 241 (2024) 109090].

Corrigendum to "Quantitative protein mass spectrometry for multiplex measurement of coagulation and fibrinolytic proteins towards clinical application: What, why and how?", [Thromb. Res. 241 (2024) 109090].

Journal: Thrombosis research

Published: August 02, 2025

Plasma proteomic profiles of patients during oral anti-coagulant treatment with vitamin K antagonists.

Plasma proteomic profiles of patients during oral anti-coagulant treatment with vitamin K antagonists.

Journal: British journal of haematology

Published: July 18, 2025

Absolute quantitative proteomics identifies patterns of plasma proteins associated with venous thromboembolism in patients with colorectal cancer.

Absolute quantitative proteomics identifies patterns of plasma proteins associated with venous thromboembolism in patients with colorectal cancer.

Journal: Thrombosis research

Published: June 13, 2025

Quantitative targeted proteomics for occult cancer screening in patients with unprovoked venous thromboembolism: results from the prospective PLATO-VTE study.

Quantitative targeted proteomics for occult cancer screening in patients with unprovoked venous thromboembolism: results from the prospective PLATO-VTE study.

Journal: Research and practice in thrombosis and haemostasis

Published: May 22, 2025

The future of siRNA-mediated approaches to treat von Willebrand disease.

The future of siRNA-mediated approaches to treat von Willebrand disease.

Journal: Expert review of hematology

Published: January 27, 2025

Showing 1-12 of 52

Last Updated: 09/26/2026